OVERVIEW

2nd International FMD Research Network and SCAD Symposium is organized by Cleveland Clinic and would be held during May 18 - 19, 2017 at Intercontinental Hotel and Conference Center, Cleveland, Ohio, United States of America.

Fibromuscular dysplasia (FMD) is an uncommon non-atherosclerotic arterial disorder that is associated with major vascular morbidity, including hypertension, stroke, arterial aneurysm and arterial dissection. More than 90% of patients with FMD are female and the average age at the time of diagnosis is approximately 52 years. Though initially described in 1938, the underlying pathophysiology and genetics of this disorder remains largely unknown and the prevalence of FMD in the general (female) population is uncertain. Though international registry efforts have advanced knowledge of the natural history of FMD, there have been no randomized clinical trials which have investigated optimal diagnostic or therapeutic strategies in FMD patients.

The proposed audience for this conference includes:
• Vascular specialists and other clinicians who care for patients with FMD (e.g., neurologists, nephrologists)
• Clinicians who care for patients with SCAD, including general and interventional cardiologists, cardiac surgeons, and rehabilitation experts
• Providers who specialize in the care of women, including women’s health specialists and obstetricians/gynecologists
• Cardiovascular translational and genetics researchers.

KEY DATES

Event Start Date
18 May, 2017
Event Start Date
Event End Date
19 May, 2017
Event End Date

SPECIALITIES

Cardiology

SUGGESTED HOTELS

CONFERENCE VENUE

LocationInterContinental Hotel & Conference Center
9801 Carnegie Ave

RELATED CONFERENCES & LIVE WEBINARS

Sep 18 - 19, 2026 | Orlando, Florida, USA

State required course for Illinois ...
23 CME/CE
More actions
US$1,695

Sep 24 - 26, 2026 | Dallas, Texas, USA

State required course for Illinois ...
33 CME/CE
More actions
US$2,295

Jul 23 - 25, 2026 | Dallas, Texas, USA

State required course for Illinois ...
34 CE/CME
More actions
US$2,295